Yet...they did buy 1 million doses of Lillys MAB for certain non critical patients .....so how come not follow up and create therapeutics for the most critical patients so they won't die ????

Because it wasn't owned by a big pharma, and our CRO seems to either be totally inept along with Mahboop and some there and ..lastly we have no lobbyists that we know of .....
Hmmmmm

We are certainly due to blow the doors off ....look how many things SHOULD happen in the first quarter and in 2022...